BIO-Key Stock Valuation

BKYI
 Stock
  

USD 1.00  0.03  3.09%   

Do you want to know what the current value of BIO-Key International is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as BIO-Key International, is its stock price multiplied by the total number of shares outstanding, calculating BIO-Key International's enterprise value requires a different approach. It uses BIO-Key International's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
BIO-Key International shows a prevailing Real Value of $2.2 per share. The current price of the firm is $1.0. Today, the firm appears to be undervalued. Our model approximates the value of BIO-Key International from reviewing the firm fundamentals such as profit margin of (1.15) %, and Return On Equity of (0.50) % as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we favor locking in undervalued instruments and disposing overvalued instruments since, in the future, asset prices and their ongoing real values will blend.
  
BIO-Key International Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as BIO-Key International's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

BIO-Key Most Recent Valuation Data

Beta
0.82
Fiscal Year End
December
property Plant And Equipment Net
323.3 K
Enterprise Value
6.5 M
current Deferred Revenue
565.4 K
net Debt
-7.5 M
Undervalued
Today 1.00
Please note that BIO-Key International's price fluctuation is very risky at this time. Calculation of the real value of BIO-Key International is based on 3 months time horizon. Increasing BIO-Key International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for BIO-Key International is useful when determining the fair value of the BIO-Key stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of BIO-Key International. Since BIO-Key International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BIO-Key Stock. However, BIO-Key International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
2.20
Real Value
6.83
Upside
Estimating the potential upside or downside of BIO-Key International helps investors to forecast how BIO-Key stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BIO-Key International more accurately as focusing exclusively on BIO-Key International's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
0.050.945.57
Details
1 Analysts
Consensus
LowTarget PriceHigh
6.006.006.00
Details

BIO-Key International Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining BIO-Key International's current stock value. Our valuation model uses many indicators to compare BIO-Key International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BIO-Key International competition to find correlations between indicators driving BIO-Key International's intrinsic value. More Info.
BIO-Key International is number one stock in beta category among related companies. It is number one stock in price to earning category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value BIO-Key International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BIO-Key International's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BIO-Key International's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BIO-Key International's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BIO-Key International and how it compares across the competition.

About BIO-Key International Valuation

The stock valuation mechanism determines the current worth of BIO-Key International on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of BIO-Key International. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of BIO-Key International based exclusively on its fundamental and basic technical indicators. By analyzing BIO-Key International's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of BIO-Key International's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of BIO-Key International. We calculate exposure to BIO-Key International's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BIO-Key International's related companies.
Fiscal Year End
December
Industry
Security & Protection Services
Concentration
Systems Software
Full Time Employees
51.0
Service Category
Software
Employer Id Number
41-1741861
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.
Continue to Trending Equities. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for analysis

When running BIO-Key International price analysis, check to measure BIO-Key International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO-Key International is operating at the current time. Most of BIO-Key International's value examination focuses on studying past and present price action to predict the probability of BIO-Key International's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO-Key International's price. Additionally, you may evaluate how the addition of BIO-Key International to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Is BIO-Key International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO-Key International. If investors know BIO-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO-Key International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
7.9 M
Quarterly Revenue Growth YOY
0.058
Return On Assets
(0.24) 
Return On Equity
(0.50) 
The market value of BIO-Key International is measured differently than its book value, which is the value of BIO-Key that is recorded on the company's balance sheet. Investors also form their own opinion of BIO-Key International's value that differs from its market value or its book value, called intrinsic value, which is BIO-Key International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO-Key International's market value can be influenced by many factors that don't directly affect BIO-Key International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO-Key International's value and its price as these two are different measures arrived at by different means. Investors typically determine BIO-Key International value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO-Key International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.